Hims & Hers Q3 revenue $226.7M (+57% YoY), adjusted EBITDA $12.3M; raises FY outlook

Hims & Hers Health, Inc.

2023-Q3 EPS reported -$0.12 revenue$625,381,000

Revenue of $226.7M for Q3 2023, up 57% YoY from $144.8M; net loss narrowed to $7.6M from $18.8M.
Adjusted EBITDA turned positive at $12.3M vs. ($6.1M) in prior year; gross margin improved to 83% from 79%.
Subscribers reached 1.4M, up 56% YoY; monthly online revenue per subscriber $54 vs. $56.
Raised full year 2023 revenue guidance to $868M-$873M and Adjusted EBITDA to $43M-$46M.
Over 80% of orders fulfilled via affiliated facilities; AI-based MedMatch service introduced to aid personalized care.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Hims & Hers Health, Inc. reported the quarter ended September 30, 2023 results: revenue $226.7 million, net income $(7.6) million. Guidance raised.

Period: the quarter ended September 30, 2023
Revenue: $226.7 million
Net income: $(7.6) million
Guidance: raised
Result: reported results

Exact text from the filing

Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook Revenue of $226.7 million, up 57% year-over-year in Q3 2023 Net loss of $7.6 million

View on SEC.gov

36 earnings releases filed in the last 30 days. Browse all earnings releases →

Hims & Hers Health, Inc. filing history →

Source: SEC EDGAR

accession 0001773751-23-000276

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.